COO DMA
COO DMA Data
As of date:9/22/2022
COO stock price:274.19
COO 50 DMA:310.60
COO 200 DMA:361.07
COO MACD (200-50):50.47

Also see:
COO Market Cap History
COO Shares Outstanding History
COO YTD Return
COO RSI
COO MACD
COO Technical Analysis

Try ChartSweeps today
Technical Analysis News

FXH Getting Very Oversold
2 hours, 18 minutes ago


FXG Crosses Critical Technical Indicator
2 hours, 20 minutes ago


Shares of FXE Now Oversold
2 hours, 22 minutes ago


Shares of FVD Now Oversold
2 hours, 22 minutes ago


FTLS Enters Oversold Territory
2 hours, 25 minutes ago


GasLog Partners (GLOP) Shares Cross Below 200 DMA
2 hours, 25 minutes ago


Antero Resources (AR) Shares Cross Below 200 DMA
2 hours, 27 minutes ago


FTEC Getting Very Oversold
2 hours, 27 minutes ago


FNDX Getting Very Oversold
2 hours, 37 minutes ago


Sisecam Resources (SIRE) Shares Cross Below 200 DMA
2 hours, 37 minutes ago


FNDF Enters Oversold Territory
2 hours, 37 minutes ago


Shares of FNDB Now Oversold
2 hours, 37 minutes ago


Western Midstream Partners Breaks Below 200-Day Moving Average - Notable for WES
2 hours, 44 minutes ago


UAN Crosses Below Key Moving Average Level
2 hours, 44 minutes ago


ARCO Makes Notable Cross Below Critical Moving Average
2 hours, 44 minutes ago


More Technical Analysis News

COO DMA Chart
COO DMACOO MACD
About Cooper Companies, Inc. (The)
Cooper Companies is a medical device company. Co.'s business units are CooperVision and CooperSurgical. CooperVision develops, manufactures and markets a range of contact lenses. CooperVision designs its products for astigmatism, presbyopia, myopia, ocular dryness and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. CooperVision also has access to myopia management and specialty eye care markets with other products, such as orthokeratology and scleral lenses. CooperSurgical focuses on improving the health of women, babies and families through a portfolio of products and services including medical devices, fertility, diagnostics and contraception.

When researching a stock like Cooper Companies, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from COO Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for COO stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the COO 200 day moving average ("COO 200 DMA"), while one of the most popular "shorter look-backs" is the COO 50 day moving average ("COO 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Cooper Companies.
Featured Slideshows
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
COO Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree COO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
COO Stock Price Chart
Video: Technical Analysis
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
COO DMA Peers
Cooper Companies (COO) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

CRL DMA
CTLT DMA
CVS DMA
DGX DMA
DHR DMA
DVA DMA
DXCM DMA
ELV DMA
EW DMA
GILD DMA
More Healthcare companies »

 

COO DMA | www.StockDMA.com | Copyright © 2019 - 2022, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.